Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: August 11, 2026 at 8:58 PM UTC
| NCT Number | NCT06661915 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 78 participants |
| Active Locations | 31 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 11, 2026 (20 hours ago) |
As of August 11, 2026: Clinical trial NCT06661915 is currently recruiting participants. This phase2 study for myeloproliferative neoplasms is actively seeking new participants at 31 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06661915 is actively recruiting participants as of August 11, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06661915 was last updated 20 hours ago (August 11, 2026). HelloStudys verifies this status automatically.